All In MedTech

Device Trial Radar · NCT00562302

Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedure

A Prospective, Randomized, Multi-centered Safety and Efficacy Evaluation of the Bio-Seal Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy

Last checked: Nov 20, 2026Latest source record: Mar 27, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 339 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

339

Actual

Start

Apr 2005

Primary completion

Jun 2008

Study completion Aug 2008

Sponsor

Lead sponsor
Angiotech PharmaceuticalsNot on our public-company list
Sponsor type
Industry
First posted
Nov 22, 2007

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

BS-1053 A Prospective Randomized Multi-Centered Safety and Efficacy Evaluation of the Bio-Seal Biopsy Track Plug for Reducing Pneumothorax Rates Post Lung Biopsy Procedures

Conditions

  • Pneumothorax

Interventions

  • Bio-Seal PlugDevice

    Deployment of the Bio-Seal plug in needle track

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence Rate of Treatment SuccessTime frame: 30 days

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Scottsdale Medical Imaging

    Scottsdale, Arizona

  • St. Josephs Radiology Limited

    Tuscon, Arizona

  • UCLA School of Medicine

    Los Angeles, California

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.